Home › Traumatic Brain Injury › California › San Diego
Traumatic Brain Injury clinical trials in San Diego, CA
5 studies for Traumatic Brain Injury are looking for participants at sites in and around San Diego (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)
RecruitingObservational study
- UCSD Medical Center - Hillcrest Hospital, San Diego
Hyperbaric Oxygen Brain Injury Treatment Trial
RecruitingPhase 2
- UCSD Medical Center - Hillcrest Hospital, San Diego
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
Recruiting
- Naval Medical Center San Diego, San Diego
Behavioral Treatment of Insomnia in Active-Duty Service Members With Traumatic Brain Injury
Recruiting
- Naval Medical Center San Diego, San Diego
Combined Transcranial Magnetic Stimulation and Therapy for MTBI Related Headaches
Recruiting
- VA San Diego Healthcare System, San Diego
About Traumatic Brain Injury
Traumatic brain injury or TBI happens when a bump, blow, or other head injury causes damage to the brain. Treatment and outcome depend on how severe.
More about Traumatic Brain Injury on MedlinePlus
Traumatic Brain Injury trials in other cities
- Boston, MA11 studies
- Minneapolis, MN10 studies
- Washington, DC8 studies
- New York City, NY7 studies
- Pittsburgh, PA7 studies
- Dallas, TX7 studies
- Cincinnati, OH6 studies
- Philadelphia, PA6 studies
- Houston, TX5 studies
- Seattle, WA5 studies
- Baltimore, MD5 studies
- St. Louis, MO4 studies
Other studies in San Diego
- Non-Small Cell Lung Cancer48 studies
- Breast Cancer41 studies
- Cancer (all types)32 studies
- Prostate Cancer31 studies
- Metastatic Cancer30 studies
- Colorectal Cancer25 studies
- Ovarian Cancer24 studies
- Pancreatic Cancer24 studies
- Lung Cancer23 studies
- Obesity23 studies
- Heart Failure23 studies
- Depression21 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.